<DOC>
	<DOCNO>NCT00252603</DOCNO>
	<brief_summary>Autism severe neurodevelopmental disorder affect 16 10,000 individual . It pervasive developmental disorder affect social , communicative , compulsive/repetitive behavior characterize stereotypic complex hand body movement , crave sameness , narrow repetitive interest . Autism severely impact affected individual family member . The propose study design assess efficacy treatment Galantamine vs. placebo childhood/adolescent autism fulfil DSM-IV Autism Diagnostic Interview ( ADI ) criterion . We therefore hypothesize : 1 . Galantamine superior placebo acute treatment global autism . 2 . Galantamine superior placebo improve functional ability . 3 . Galantamine superior placebo improve language function . 4 . Galantamine superior placebo improve irritable hyperactive behavior . 5 . Galantamine superior placebo improve social deficit .</brief_summary>
	<brief_title>Galantamine Versus Placebo Childhood Autism</brief_title>
	<detailed_description>Once enrol study , subject receive evaluation test determine meet necessary criterion admission study treatment . Subjects responsible cost evaluation test conduct part study . First , subject receive psychiatric medical evaluation study psychiatrist see she/he psychiatric medical illness would interfere ability participate study . These evaluation may take hour complete . In addition , subject ask participate psychiatric interview design determine child ’ diagnosis current problem area . The subject ’ parent also ask fill psychiatric questionnaire . The interview questionnaires may take 4 hour complete . Second , urine blood sample need routine test two time study ( study relate test do , end study ) . Two teaspoon blood drawn time . The urine sample analyze order ass kidney function screen presence drug ( cocaine , marijuana , heroin , etc. ) . A positive drug screen would result inability child participate study . Drug screen result keep confidential . In addition , electrocardiogram perform determine heartbeat . Lastly , pregnancy test conduct urine sample child female reach puberty . The child study pregnant nursing mother . A positive urine pregnancy test would cause child remove study . If child sexually active , must use effective method birth control participation study . Acceptable method birth control oral contraceptive medication ( administration must parentally supervise ) , IUD , depot medication tubal ligation . Subjects assign chance receive either active medication ( Galantamine ) placebo ( sugar pill ) 12 week , much like flip coin . Neither parent/child investigator know two treatment child receive . The child 50 % chance assign receive placebo study active medication , Galantamine , study . The child need see weekly study psychiatrist first 4 week twelve-week study , every week remain week study . During visit study psychiatrist ask parent feedback his/her child ’ condition change may relate medication , include possible side effect , nausea headache , check child ’ condition . The psychiatrist also record his/her weight . These study visit generally last approximately 30 minute .</detailed_description>
	<mesh_term>Autistic Disorder</mesh_term>
	<mesh_term>Galantamine</mesh_term>
	<criteria>1 . Meets DSMIV , ADIR ADOSG criterion autistic disorder 2 . Age 517 year 3 . Outpatients 4 . Parent legal guardian willing sign inform consent . 5 . Male female patient 6 . Patient score least “ 4 ” ( moderately ill ) Clinical Global Impression Scale Autistic Disorder ( CGI AD ) . 7 . Children minimally non verbal indicate score 50 % 18 month old MacArthur Communicative Development Inventory 1 . Subjects follow past present mental disorder : psychotic disorder , mood disorder , include bipolar disorder . 2 . Subjects display significant selfinjurious behavior ( child cause visible harm ) . 3 . Subjects active seizure disorder ( seizure within past six month ) . 4 . Subjects clinically significant unstable medical illness , include patient current evidence clinically significant hematopoietic , cardiovascular disease . 5 . Subjects present history following : gastrointestinal , liver , kidney , know condition presently interfere absorption , distribution , metabolism , excretion drug , seizure disorder ( active ) , cerebrovascular disease brain trauma etiology autistic behavior , clinically significant unstable endocrine disorder , hypo hyperthyroidism diabetes , recent history presence form malignancy . 6 . Subjects report significant improvement autism symptom behavior current medication global autism rating CGI absent , minimal mild severity , minimally verbal . 7 . Subjects whose global autism rating assess absent , minimal mild . 8 . Treatment within previous 30 day drug know welldefined potential toxicity major organ . 9 . Subjects clinically significant abnormality laboratory test physical exam . 10 . Subjects likely require psychotropic medication study , exception clonidine insomnia ( start least one month prior entrance study ) , well anticonvulsant constant dose stable seizure disorder , unless otherwise permit . 11 . Subjects unable tolerate taper psychoactive medication , specify . 12 . Subjects history hypersensitivity severe side effect associate use galantamine , acetylcholinesterase inhibitor . 13 . Subjects history prior treatment galantamine 4mg/day 6 week . 14 . Subjects receive follow intervention within prescribed period start treatment : investigational drug within previous 30 day . monoamine oxidase inhibitor within previous fourteen day . longacting phenothiazine within previous six week . psychotropic drug within previous seven day , unless otherwise permit . 15 . Subjects organic systemic disease patient require therapeutic intervention , otherwise specify , would confound evaluation safety study medication . 16 . Subjects reside remote geographical area regular access transportation clinical facility . Gender</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>January 2007</verification_date>
	<keyword>Autism</keyword>
	<keyword>Childhood Autism</keyword>
</DOC>